Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
04/1998
04/01/1998EP0831925A1 The regulation of systemic immune responses utilizing cytokines and antigens
04/01/1998EP0831924A1 Method of treatment for asthma
04/01/1998EP0831923A1 Separation of active complexes
04/01/1998EP0831922A2 Improved pharmaceutical compositions for gene therapy
04/01/1998EP0831921A1 Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
04/01/1998EP0831920A1 Novel cathepsin and methods and compositions for inhibition thereof
04/01/1998EP0831919A1 Method for pharmaceutical delivery
04/01/1998EP0831917A2 Immunotoxins specific for cd80 and cd86 expressing cells
04/01/1998EP0831905A1 Methods of treating colon cancer utilizing tumor-specific antibodies
04/01/1998EP0831904A1 Treatment and diagnosis of prostate cancer
04/01/1998EP0831903A1 Connective tissue growth factor
04/01/1998EP0831899A1 Recombinant poxvirus-calicivirus rabbit hemorrhagic disease virus (rhdv)] compositions and uses
04/01/1998EP0831885A1 Methods and uses of connective tissue growth factor as an induction agent
04/01/1998EP0831880A1 Antibody and antibody fragments for inhibiting the growth of tumors
04/01/1998EP0831879A1 Method for identifying or isolating a molecule and molecules identified thereby
04/01/1998EP0831875A1 Methods of inhibiting phagocytosis
04/01/1998EP0831874A1 Gene therapy for myocardial ischemia
04/01/1998EP0831871A1 Relaxin-like factor and methods and uses thereof
04/01/1998EP0831866A1 Pineal gland specific gene-1
04/01/1998EP0831854A1 Oligonucleotides having phosphorothioate linkages of high chiral purity
04/01/1998EP0831850A1 Use of locally applied dna fragments
04/01/1998EP0831848A1 Method of treatment for lung diseases using antisense oligonucleotides
04/01/1998EP0831846A1 Capped synthetic rna, analogs, and aptamers
04/01/1998EP0831708A1 Methods for producing a potentiator of bacillus pesticidal activity
04/01/1998EP0831695A1 Bacteria having nematicidal activity and their agricultural use
04/01/1998EP0831689A1 Use of the indeterminate gametophyte gene for maize improvement
04/01/1998EP0831688A1 Process for the preparation of antiviral plant transformed with lactoferrin gene
04/01/1998EP0792352A4 Enhanced carotenoid accumulation in storage organs of genetically engineered plants
04/01/1998EP0748390A4 Comparative gene transcript analysis
04/01/1998EP0637318B1 Peptide derivatives corresponding to the carboxy terminal sequence of hirudin
04/01/1998EP0507852B1 Gene deleted in colorectal cancer of humans
04/01/1998CN1177982A System for the expression of heterologous antigens as fusion proteins
04/01/1998CN1177981A Dna序列 Dna sequence
04/01/1998CN1177980A Mycobacterial proteins, microorganisms producing same and uses of said proteins in vaccines and for detecting tuberculosis
04/01/1998CN1177928A Generation of human insulin
04/01/1998CN1177909A Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria
04/01/1998CN1177640A Improved heat-stable DNA polymerase
04/01/1998CN1177639A Modification of xylanase to improve thermophilicity, alkophilicity and thermostability
04/01/1998CN1037913C Code insect-killing protein fusion gene and expressive carrier and use
03/1998
03/31/1998US5734041 Preparation of chiral phosphorothioate oligomers
03/31/1998US5734040 Positively charged oligonucleotides as regulators of gene expression
03/31/1998US5734039 Antisense oligonucleotides targeting cooperating oncogenes
03/31/1998US5734038 Purified polynucleotide sequence which codes for a diazepam binding inhibitor protein(or polypeptide) or an acyl-coenzyme a binding protein(or polypeptide)
03/31/1998US5734037 DNA encoding the human cytokine, interleukin-9
03/31/1998US5734036 Nucleic acids encoding transcriptional activators
03/31/1998US5734035 Nematode vaccine
03/31/1998US5734034 Nucleic acid ligand inhibitors of human neutrophil elastase
03/31/1998US5734033 Antisense oligonucleotides inhibiting human bcl-2 gene expression
03/31/1998US5734032 Photo-induced DNA-cleaving agents
03/31/1998US5734021 Having an amino acid sequence as set forth as seq id #2; genetic engineering
03/31/1998US5734019 Hepatitis C virus antigen polypeptide, production method therefor, and antibody detection method
03/31/1998US5734016 Genetic engineering
03/31/1998US5734015 Antibiotics
03/31/1998US5734014 Polypeptide
03/31/1998US5733893 Binding of fibroblast growth factor to oligosaccharides
03/31/1998US5733876 Method of inhibiting angiogenesis
03/31/1998US5733875 Epilepsy
03/31/1998US5733790 CRF binding protein antibodies and assays using same
03/31/1998US5733782 Methods and compositions for high protein production from non-native DNA
03/31/1998US5733781 Dna and human immunodefficiency virus inhibitors
03/31/1998US5733780 Construction of Pasteurella haemolytica vaccines
03/31/1998US5733779 Impaired dominant selectable marker sequence and intronic insertion strategies for enhancement of expression of gene product and expression vector systems comprising same
03/31/1998US5733778 Vaccines, medical diagnosis
03/31/1998US5733773 Dna molecules and genetic engineering ffrom rhodococcus
03/31/1998US5733772 Cloning and expression of Plasmodium falciparum transmission blocking target antigen, Pfs230
03/31/1998US5733771 cDNAs encoding minor ampullate spider silk proteins
03/31/1998US5733768 Amyloid precursor protein protease
03/31/1998US5733765 A polypeptide producing a heteropolysaccharide
03/31/1998US5733762 Conjugated glycoproteins for drug delivery
03/31/1998US5733761 Gene therapy
03/31/1998US5733760 Salmonella vectors encoding truncated pag fusion protein, method of making, and uses thereof
03/31/1998US5733759 Methods for the regulation of plant fertility
03/31/1998US5733757 Aldol condensations for antibodies
03/31/1998US5733753 Amplification of genomic DNA by site specific integration of a selectable marker construct
03/31/1998US5733752 Detection of nucleic acids in cells by thermophilic strand displacement amplification
03/31/1998US5733749 Glycerol phosphatase with stereo-specific activity
03/31/1998US5733745 Pure genetic engineered protein
03/31/1998US5733744 Binary BAC vector
03/31/1998US5733743 Genetic engineering
03/31/1998US5733740 Taga gene and methods for detecting predisposition to peptic ulceration and gastric carcinoma
03/31/1998US5733731 Transforming cells; vectors that encodes a fusion protein comprised of a dna binding protein and a random peptide
03/31/1998US5733730 Telomere repeat binding factor and diagnostic and therapeutic use thereof
03/31/1998US5733727 Myocardial grafts and cellular compositions
03/31/1998US5733726 Cytotoxicity-based genetic selection system (TOXSEL)
03/31/1998US5733724 Polypeptides
03/31/1998US5733723 Bacillus for genes and dna sequences
03/31/1998US5733720 Dna-transfected cell line susceptible to infection by herpes virus which is stably transformed with chimeric gene comprising herpes virus inducible promoter and gene coding for an enzyme, the expression of which is dependent on virus
03/31/1998US5733600 Method and apparatus for preparing sample cartridges for a particle acceleration device
03/31/1998US5733556 Newcastle disease virus combination vaccine
03/31/1998US5733554 Avian herpesvirus-based live recombinant avian vaccine, in particular against Gumboro disease
03/31/1998US5733553 Nucleotide sequence
03/31/1998US5733548 Stimulating t-cell response
03/31/1998US5733543 Genetic engineering; delaying acquired immune deficiency syndrome (aids) onset
03/31/1998US5733540 Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria
03/31/1998US5733442 Microdialysis/Microelectrodialysis system
03/31/1998CA2186833A1 Seed coat dna regulatory region and peroxidase
03/26/1998WO1998012563A1 Method to detect dirofilaria immitis infection
03/26/1998WO1998012354A1 Identification of molecular sequence signatures and methods involving the same
03/26/1998WO1998012351A1 Method for purifying and eventually analyzing nucleic acids from biological test samples
03/26/1998WO1998012345A1 CEPHALOSPORIN ESTERASE GENE FROM $i(RHODOSPORIDIUM TORULOIDES)
1 ... 3545 3546 3547 3548 3549 3550 3551 3552 3553 3554 3555 3556 3557 3558 3559 3560 3561 3562 3563 3564 3565 ... 4023